Blog
Schindler Holding Ltd.: Changes to the Group Executive Committee
Schindler Holding Ltd.: Changes to the Group Executive Committee
Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc: POS-Transaction in Own Shares
2CRSi SA: 2CRSi Wins a €7.4M Bid for AI Training and Research in France
2CRSi SA: 2CRSi Wins a €7.4M Bid for AI Training and Research in France
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius announces its intention to reduce its stake in Fresenius Medical Care AG from currently around 32.2% to no less than 25% plus one share
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius announces its intention to reduce its stake in Fresenius Medical Care AG from currently around 32.2% to no less than 25% plus one share
Key Figures 28.02.2025
Key Figures
28.02.2025
VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms its strategic and financial goals
VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms its strategic and financial goals
Alzchem Group invites you to the Creatine Conference 2025: Munich is becoming a hotspot for creatine research
Alzchem Group invites you to the Creatine Conference 2025: Munich is becoming a hotspot for creatine research
HOL-Holding(s) in Company
HOL-Holding(s) in Company
EQS-Adhoc: Delticom AG carries out a further share buyback program in the amount of up to 100,000 own shares
EQS-Adhoc: Delticom AG carries out a further share buyback program in the amount of up to 100,000 own shares
EQS-News: Share Buyback
EQS-News: Share Buyback
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Form 8.3 - The Vanguard Group, Inc.: Renewi plc
Form 8.3 - The Vanguard Group, Inc.: Renewi plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The
Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Form 8.3 - The Vanguard Group, Inc.: Wood Group (John) plc
Form 8.3 - The Vanguard Group, Inc.: Wood Group (John) plc
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc
Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc
EQS-News: Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG
EQS-News: Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG
EQS-News: Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
EQS-News: Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
EQS-News: FYB202/Otulfi® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United States and the European Union
EQS-News: FYB202/Otulfi® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United States and the European Union


